András M.
- Country
- Hungary
- Department
- 7817: Kardiológia Osztály és Koronária Őrző
Research Overview
Data & Insights
Has run more than one trial at 19 of 372 partner sites.
Specializations
Cardiovascular disease and thromboembolic prevention
András Matoltsy is involved in clinical research focused on atherosclerotic cardiovascular disease, heart failure, and prevention of stroke in patients with atrial fibrillation or recent ischemic events.
- Secondary stroke prevention
- Atrial fibrillation–related embolic risk
- Lipid-lowering and vascular risk reduction
- Heart failure symptom and outcome management
His research landscape also includes therapies aimed at reducing major cardiovascular events and improving long-term vascular protection in high-risk patients.
Metabolic disease and obesity
His trial activity extends to type 2 diabetes mellitus, obesity, and overweight, with interest in treatments that improve glycaemic control and reduce cardiometabolic risk.
- Type 2 diabetes management
- Weight reduction strategies
- Cardiometabolic risk modification
- Long-term morbidity and mortality reduction
This area includes therapies evaluated for both metabolic control and downstream cardiovascular benefit.
Renal disease and kidney protection
He is also engaged in research on non-diabetic chronic kidney disease, reflecting interest in therapies designed to slow renal decline and preserve kidney function.
- Chronic kidney disease
- Progression delay in renal impairment
- Cardiorenal protection
These studies align with clinical priorities in patients at risk of combined renal and cardiovascular complications.
Respiratory medicine and asthma
Another area of involvement is asthma, including pediatric respiratory care and the evaluation of inhaled therapies aimed at improving lung function and symptom control.
- Pediatric asthma
- Airflow limitation
- Inhaled bronchodilator and corticosteroid therapy
This research domain supports treatment development for younger patients with persistent respiratory disease.
Infectious diseases and anti-infective therapy
His clinical trial portfolio includes bloodstream infection, sepsis, complicated urinary tract infection, complicated intra-abdominal infection, and hospital-acquired pneumonia, with attention to infections caused by gram-negative pathogens.
- Severe bacterial infection
- Hospital-acquired and ventilator-associated pneumonia
- Complicated urinary and abdominal infections
- Pediatric anti-infective treatment
He is also involved in studies spanning neonatal and pediatric infection management, adding an important infectious-disease dimension to his research profile.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.